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 Abstract 
EMSA Eritin is a medicinal polyherbal contains with soy bean, coconut water and red rice extract. In several 
studies of this individual components have proven the potential to modulate lymphocyte cells that 
indirectly lowering blood glucose levels in diabetes meliitus. This study was aimed to analyzing the effect of 
polyherbal EMSA Eritin on the expression of CD4
+
, CD8
+
 and SDF-1 cells population in mice model of 
diabetes mellitus. Neonatal d-5 mice was intraperitoneally injected with Streptozotocin (STZ) 100 mg.kg-1 
BW. Four weeks post injection the mice was treated with EMSA Eritin in three doses 0.3125 mg.g-1 BW, 
3.125 mg.g-1 BW and 31.25 mg.g-1 BW for 14 days. Cells Profile of T lymphocyte (CD4+ and CD8+) and 
chemokine SDF-1 were analyzed by Flow cytometry. Data were analyzed with One-way ANOVA (p<0.05) and 
Duncan test using SPSS 16.0 for Windows. The result showed that EMSA Eritin significantly increased T 
lymphocyte (CD4+ and CD8+) in optimum dose 3.125 mg.g-1 BW and suppress SDF-1 production in high dose 
(31.25 mg.g-1 BW) as well as the blood glucose level measurement. This study suggest that polyherbal EMSA 
Eritin has a potential to decreased blood glucose level in mice model of diabetes mellitus.  
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INTRODUCTION 
Diabetes mellitus (DM) has become one of 
the major causes of morbidity and mortality in 
the world with increasing prevalence where 3.4 
million people died in 2004. It is predicted to be 
doubled in 2030 which makes this metabolic 
disorder one of the leading death cause in the 
world. Diabetes mellitus is a metabolic disease 
characterized by hyperglycemia, caused by the 
loss of glucose homeostasis in blood [1,2].  
Diabetes has a several complications that can 
cause systemic disorders in some organs, inclu-
ding cellular immune system, e.g. lymphocytes, 
monocytes, neutrophils and macrophages that 
can lead to cell death [3]. Some studies suggest 
that patients with diabetes have an increased 
apoptotic cell death in lymphocyte from the 
peripheral blood vessels, and other pathogens. 
Influence exerted by reduced the number of 
CD4+ and CD8+ T cells and also affecting lympho-
poiesis [4,5,6]. CD4+ is a marker in T cell known as 
T-helper cell that can help activate B cells to 
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secrete antibodies and macrophages to destroy 
foreign substance, and also activated CD8+ 
known as T-cytotoxic cell to kill infected target 
cells. CD4+ T cells along with CD8+T cells make up 
the majority of T-lymphocytes and plays impor-
tant roles in immune system [7]. Immune system 
dysfunction in diabetic patients also occurs in 
polymorphonuclear cells (PMN) such as chemo-
taxis and phagocytosis as well [8]. Chemotaxis as 
a chemoattractant are postulated to help direct 
lymphocyte traffic into sites of inflammation and 
into lymphoid and non-lymphoid tissues during 
recirculation. Stromal cell-derived factor-1 or 
SDF-1 is known to be a highly efficacious chemo-
attractant for T lymphocytes and has a complex 
effects on migration, proliferation, and differenti-
ation of leukocytes [9]. Reduced number of T 
lymphocytes in patients with diabetes mellitus 
caused by hyperglycemia that increase reactive 
oxygen species (ROS) and excess produce of 
superoxide in the body. This immune disorders 
are known to be a stressor that affects the 
immune modulation and play an important 
pathogenic role in immunodeficiency [10,11]. 
In traditional medicine, a mixture of several 
species of herbs known as poliherbal has 
comprising prescriptions that can improve body 
defense mechanisms [12]. EMSA Eritin is a 
mixture of three edible medicinal herbal, consist 
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of soybean (Glycine max), water coconut (Cocos 
nucifera) and red rice (Oryza sp.) extract. Several 
studies of EMSA Eritin individual components 
have proven they have a potential to lowering 
blood glucose levels in diabetes mellitus [13-16]. 
This study was aimed to determine the 
expression of CD4+, CD8+ and SDF-1 cells 
population in thymus of mice (Mus musculus) 
model of diabetes mellitus after EMSA Eritin 
administration. 
 
MATERIALS AND METHODS 
Mice 
In this study we used a total 25 neonatal 5-
day-old Balb/C mice with ± 2.5 g body weight. 
Mice were taken care in free pahtogen animal 
chamber, Departement of Biology, Faculty of 
Mathematic and Natural Sciences, University of 
Brawijaya, Malang, East Java, Indonesia. 
This research has obtained an ethical 
clearence certificate from Brawijaya University 
Research Ethics Committee. No: KEP-385-UB. 
 
Induction of Diabetes mellitus 
Neonatal d-5 Balb/C mice was intraperi-
toneally injected with 50 µL Streptozotocin 100 
mg.kg-1 BW (0.005  mg STZ was dissolved in 1 mL 
of 0,1 M citrate buffer pH 4.5) [17].  Mice were 
divided into five experiment group; three 
treatment group (low, optimum and high doses) 
and two control group (positive and negative). 
Mice from all treatment group and positive 
control group were injected with STZ. Blood 
glucose level then measure when mice at the 
ages 4-5 weeks post injection. 
 
Administration of EMSA Eritin 
Polyherbal EMSA Eritin was given orally for 14 
days in three group doses: low dose (0.3125 
mg.g-1 BW), optimum dose (3.125 mg.g-1 BW) and 
high dose (31.25 mg.g-1 BW). Determination of 
EMSA Eritin doses for each treatment group were 
based on the human consumption of 60 kg BW 
that consumed about 15 g of EMSA Eritin. Poly-
herbal EMSA Eritin was derived from Royal 
Medicalink Pharmalab Company, Makassar, Indo-
nesia.  
 
Blood Glucose Measurement 
Measurement of blood glucose levels was 
done every three days with One Touch Ultra© 
glucometer. Blood sampling was taken from the 
mice tails, blood was dropped in the glucostick 
and wait for the value appear on the glucometer 
screen. Mice with blood glucose levels over than 
200 mg.dl-1 is declared as a type 2 diabetes 
mellitus [18]. 
 
Cell Isolation from Thymus 
Lymphocyte and chemokine cells was isolated 
from thymus. Mice were killed by cervical 
dislocation and surgery with an incision in the 
abdominal region of mice. Thymus was cleaned, 
crushed and filtered with PBS to separate from 
fat tissue. The suspension then put into poly-
propylene tube and added with PBS until 10 mL 
and put it in centrifuge (2500 rpm for 5 min at 
4°C). The supernatant was discarded and the 
obtained pellet was resuspensed with 1 mL PBS, 
and put into micro tube, added PBS and 
centrifuged again (2500 rpm for 5 min at 4°C). 
The suspended cells ready to proceed for 
intracellular staining. 
 
Intracellular Staining and Flowcytometry  
Intracellular staining was performed from the 
suspended isolation cells and incubated with 40 
µL antibody (FITC-conjugated anti-mouse CD4, 
PE-conjugated anti-mouse CD8) Catalogue No. 
100531, 100708, BioLegend, San Diego, CA, USA 
for 20 minutes. After incubation, resuspended 
using 100 µL cytofix buffer and incubated for 20 
minutes in dark condition, at 4°C. Sample then 
resuspended with 500 µL wash-perm and 
centrifuged (2500 rpm at 4° C for 5 min). The 
supernatant was discarded and pellet was added 
with PE-Cy5-conjugated anti-mouse SDF-1 
(Catalogue No. IC350C, BioLegend, San Diego, CA, 
USA) and incubated for 20 minutes. Sample then 
added with 300 µL of PBS, transferred into flow 
cytometry cuvette and ready for running with BD 
Biosciences FACS CaliburTM nozzle flow cytometry 
using BD CellQuest software settings PRO
TM
. 
 
Statistical Analysis 
Data from this study were analyzed 
statistically by One way ANOVA (Analysis of 
Variance) with p<0.05 to assess the statistical 
difference between experiment group and 
continued with Duncan test using SPSS 16.0 for 
Windows. 
 
RESULT AND DISCUSSION  
Blood Glucose level 
Blood glucose level is the amount of glucose 
that present and transported through the 
bloodstream to supply energy to all the  cells in 
our bodies. The body naturally regulates blood 
glucose levels as a part of metabolic homeostatis. 
Based on obtained data from treatment and 
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control group of the blood glucose levels 
measurements showed a varying result (Fig. 1). 
Blood glucose levels in NON-DM group still on 
the normal range between 95-134 mg.dL-1 
whereas blood glucose levels in DM group was 
approved to be a hyperglycemia because it is 
over than 200 mg.dL-1 [18]. The treatment group 
at low dose (0.3125 mg.g-1BW) showed a 
fluctuated blood glucose levels. The blood glucoe 
level was decreased from the start and increased 
at the 12th day of measurement, as well as the 
high dose (31.25 mg.g-1BW) level of blood 
glucose was extremely fluctuated with final 
measurement blood glucose level are 133.8 
mg.dL-1. While the treatment group at optimum 
dose (3.125 mg.g-1BW) showed a gradually decre-
ase blood sugar levels even though the final 
measurement blood glucose level is 231 mg.dL-1. 
The mean result of statistical analysis showed 
there are significantly different blood glucose 
level between the treatment and control group 
(p<0.05), even though there are no significant 
difference within the treatment group (p>0.05).  
The changes of blood sugar level may be 
influenced by several factors, for example the 
endurance from each mice to response free 
radicals that damage the pancreas due to STZ 
injection, hormonal factors in the body that 
affect insulin production and environmental 
factors such as stress that suffered from the 
treatment [19]. 
 
Profile Population of T cells CD4+ and CD8+ 
T cells CD4+ and CD8+ is a trans membrane 
protein that has a function as co-receptor on T 
lymphocytes with a different roles. T cells 
populating the peripheral blood or secondary 
lymphoid organs were distinguished by the 
expression of CD4+ and CD8+ T cells based on the 
use of particular monoclonal antibodies. The 
expression of CD4+ and CD8+ was linked to 
different T cell functions; in the case of CD4+ 
known as T-helper, augmenting the ability of B 
cells to produce antibodies and help activate 
other immune cell including CD8+ T cell that 
known as T-cytotoxic cell causing direct 
cytotoxicity of infected target cell. T lymphocyte 
cell derived from hematopoietic stem cell (HSC) 
in bone marrow (BM) and differentiated into 
lymphoid progenitor became precursor T cells 
and  migrate from BM to thymus for further 
maturation became T cells mature single positive 
(CD4+ and CD8+). The development of primary 
CD8+ T cell responses is thought to be assisted 
directly by CD4+ T cells in two ways; the 
activation of professional APC and the secretion 
of cytokines [7,8]. 
Based on T lymphocytes relative number from 
flow cytometry analysis (Fig. 2), the entire 
experimental group in a healthy state because 
CD4+ T cell population is higher than CD8+ T cell 
population [20]. T Cells Population of CD4+ and 
CD8+ in all treatment group was increased 
compare to DM control group, the relative 
number of CD4+ T cell treatment group as 
follows; DM-D1 (0.3125 mg.g-1 BW) 12.69%, DM-
D2 (3.125 mg.g-1 BW) 15.19%, and DM-D3 (31.25 
mg.g-1 BW) 13, 32% has increased compare to 
DM group. Same condition in CD8+ T cell 
population relative number as follows; DM-D1 
(0.3125 mg.g-1 BW) 5.12%, DM-D2 (3.125 mg.g-1 
BW) 5.43%, and DM-D3 (31.25 mg.g-1 BW) 4, 52% 
also increased from DM group. The relative 
number of  T cell CD4+ and CD8+ population in all 
treatment group was significantly increased 
compare to DM group (p<0.05), although there 
are no significantly differences within the 
treatment group. 
The increasing of T cell CD4+ and CD8+ 
population in thymus after administration of 
EMSA Eritin was assumed because of the 
antioxidants compound such as flavonoids and 
anthocyanin  that contained in soy beans and red 
rice extract. The possible mechanisms [12,13,15], 
antioxidant is known to have a role as an 
immunomodulatory that is able to induce and 
increase the secretion of cytokines IFN-γ to 
produce IL-2 that may involved in cell activation 
of T lymphocytes. The increased cell activation is 
caused by flavonol glycosides in flavonoids that 
can act as a mitogen and induced timosit to 
stimulate the secretion of cytokines which will 
increase the receptor expression of mature T 
lymphocytes (CD4+ and CD8+). Another content 
of active compounds such as saponins also able 
to play a role in triggering the activation of IFN-γ. 
Which in turn stimulates the expression of MHC-
II, thereby increasing the CD4+ T cell proliferation 
which affect the CD8+ T cell activation [21,22]. 
Exposed naïve T antigen and antigen presented 
by APC will develop into a subset of T cells CD4+ 
and CD8+. CD4+ T cells will develop into Th1 and 
Th2 subsets, where Th1 is contributed to the 
production of cytokines IL-2 and IFN-γ which 
activate the CD8+ T cell immune cell function. 
Mechanism action of CD4+ as a modulator of the 
immune system derived from the activity of 
some cytokines such as IL-1, IL-2 and IFN-γ also to 
induce CD8+ T cell maturation [23,24]. 
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Figure 1. Measurement of blood glucose level. (NON-DM) nondiabetic mice as negative control group without any 
treatment. (DM) diabetic mice as positive control group, treated with injection of Streptozotocin 100 mg.kg-1. (DM-
D1) DM mice treated with EMSA Eritin at low dose 0.3125 mg.g-1 BW. (DM-D2) DM mice treated with EMSA Eritin 
at optimum dose 3.125 mg.g-1 BW. (DM-D3) DM mice treated with EMSA Eritin at high dose 31.25 mg.g-1 BW. 
 
Figure 2. Cells population of CD4+ and CD8+ T cells were increased in all treatment group. (A) The results of flow-cytometry 
analysis (B) Mean of percentage relative number from five group. Differences notation indicates significant 
difference (p<0.05). (NON-DM) nondiabetic mice as negative control group without any treatment. (DM) diabetic 
mice as positive control group, treated with injection of Streptozotocin 100 mg.kg-1. (DM-D1) DM mice treated with 
EMSA Eritin at low dose 0.3125 mg.g-1 BW. (DM-D2) DM mice treated with EMSA Eritin at optimum dose 3.125mg.g-1 
BW. (DM-D3) DM mice treated with EMSA Eritin at high dose 31.25 mg.g-1 BW. 
 
Profile Population of SDF-1 Chemokine 
Stromal Cell-Derived Factor-1 (SDF-1), is a CXC 
chemokine stromal derived from bone marrow. 
Chemokines are a family on chemoattratractant 
polypeptides that classified into 4 groups, de-
pend on the position of conserved cysteine 
residues. Chemokines mediate their effect by 
binding to transmembrane G protein–coupled 
co-receptors CXCR4. Major role of chemokines is 
chemoattractant to guide the migration of cells. 
Chemokines-attracted cells follow a signal of 
increasing chemokine concentration towards the 
source. Some chemokines control mobilization 
cells of the immune system during processes of 
immune surveillance such as leukocyte subsets to 
inflammation sites [25,26]. 
Flowcytometry analysis and relative number 
of SDF-1 cells showed varying results between 
the group. SDF-1 relative number increased 
gradually in DM-D1 and DM-D2 but decreased in 
high dose (DM-D3) 0.69%. The relative number of 
SDF-1 cells population was significantly differ-
ences between treatment and control group 
(p<0.05) (Fig. 3). Increased population of SDF-1 in 
DM-D2 (3.125 mg.g-1 BW) 1.76% presumably 
cause by the expression of SDF-1 as chemo-
attractant. It released signal by injured cells or 
tisue in thymus lead to increased level of SDF-1 
at the inflammation site. While in high dose 
(31.25 mg.g-1 BW), expression of SDF-1 decreased 
probably due to recovery from the active 
compound flavonoid from soy bean (G. max) as 
an antioxidant at the site of inflammation [21]. 
(A) (B) 
a 
b 
b 
b 
b 
mn 
m 
n n 
n 
 J.Exp. Life Sci. Vol. 5 No. 1, 2015  ISSN. 2087-2852 
  E-ISSN. 2338-1655 
48 Potential EMSA Eritin to Modulate T Cells in Diabetic Balb/C Mice 
(Rohie and Rifa’i) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Cells population of SDF-1 in thymus. (A) The results of flow-cytometry analysis (B) Mean of percentage relative 
number from five group. Differences notation indicates significant difference (p<0.05). (NON-DM) nondiabetic mice 
as negative control group without any treatment. (DM) diabetic mice as positive control group, treated with 
injection of Streptozotocin 100 mg.kg-1. (DM-D1) DM mice treated with EMSA Eritin at low dose 0.3125 mg.g-1 BW. 
(DM-D2) DM mice treated with EMSA Eritin at optimum dose 3.125 mg.g-1 BW. (DM-D3) DM mice treated with 
EMSA Eritin at high dose 31.25 mg.g-1 BW. 
 
Polyherbal EMSA Eritin is known to have 
antioxidant form of isoflavones and anthocyanins 
derived from soy beans and red rice extract. 
Isoflavones are flavonoid group commonly found 
in soybeans and has beneficial effect on diabetic 
patients by eliminating the direct oxygen free 
radicals, increasing the concentration of antioxi-
dant enzymes and increases serum insulin and 
pancreatic insulin component [13]. Genistein, a 
component of isoflavones, have the effect of 
lowering blood glucose by increasing insulin 
production and glucose uptake by cells [14]. Just 
like isoflavones, anthocyanins protect pancreatic 
cells from oxidative stress, lowers blood glucose 
levels by increasing insulin receptors work, 
improve antioxidant status by pressing malon-
dialdehyde and improve the level of superoxide 
dismutase [16]. Compared to individual compo-
nent from different studies, polyherbal EMSA 
Eritin can also lowering the blood glucose 
through the improvement of T lymphocyte cell 
(CD4+ and CD8+) and chemokine SDF-1 
modulation in thymus mice model of diabetes 
mellitus in this experiment. 
 
CONCLUSION 
Polyherbal EMSA Eritin can modulate T 
lymphocytes (CD4+ and CD8+) in optimum dose 
3.125 mg.g-1 BW and supress SDF-1production in 
high dose (31.25 mg.g-1 BW) as well as the blood 
glucose level measurement. This study suggest 
that EMSA Eritin is a potential polyherbal that 
can be used as a therapy for diabetes. 
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